Literature DB >> 17996535

Successive determination of urinary protein and glucose using spectrophotometric sequential injection method.

Watla-iad Kanchana1, Tadao Sakai, Norio Teshima, Shuji Katoh, Kate Grudpan.   

Abstract

A new sequential injection (SI) system with spectrophotometric detections has been developed for successive determination of protein and glucose. The protein assay is based on ion-association of protein with tetrabromophenolphthalein ethyl ester (TBPE) in the presence of Triton X-100 at pH 3.2. The blue product is monitored for absorbance at 607 nm. For glucose, hydrogen peroxide, generated by the oxidation of glucose in the presence of glucose oxidase immobilized on glass beads packed in a minicolumn, is monitored using iron-catalyzed oxidation reaction of p-anisidine to form a red colored product (520 nm). The SI procedure takes advantage in performing the protein assay during the incubation period for glucose oxidation. Linear ranges were up to 10 mg dL(-1) human serum albumin (HSA) with a limit of detection (LOD) (3sigma) of 0.3 mg dL(-1), and up to 12.5 mg dL(-1) glucose with LOD of 0.08 mg dL(-1). R.S.D.s (n=11) were 2.7% and 2.5% (for 1 mg dL(-1) and 5 mg dL(-1) HSA) and 1.4% (9 mg dL(-1) glucose). Sample throughput for the whole assay of both protein and glucose is 6 h(-1). The automated system has been demonstrated for the successive assay of protein and glucose in urine samples taken from diabetic disease patients, with good agreement with the other methods. This developed SI system is an alternative automation for screening for diabetic diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996535     DOI: 10.1016/j.aca.2007.10.010

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  6 in total

1.  Evaluation of luminol chemiluminescence based on simultaneous introducing of coumarin derivatives as green fluorophores and chitosan-induced Au/Ag alloy nanoparticle as catalyst for the sensitive determination of glucose.

Authors:  M J Chaichi; S O Alijanpour; S Asghari; S Shadlou
Journal:  J Fluoresc       Date:  2015-02-03       Impact factor: 2.217

2.  Flow injection/sequential injection analysis systems: potential use as tools for rapid liver diseases biomarker study.

Authors:  Supaporn Kradtap Hartwell
Journal:  Int J Hepatol       Date:  2012-03-18

3.  Ascorbic Acid Protects against Hypertension through Downregulation of ACE1 Gene Expression Mediated by Histone Deacetylation in Prenatal Inflammation-Induced Offspring.

Authors:  Jing Wang; Na Yin; Youcai Deng; Yanling Wei; Yinhu Huang; Xiaoyun Pu; Li Li; Yingru Zheng; Jianxin Guo; Jianhua Yu; Xiaohui Li; Ping Yi
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

4.  Label-Free and Regenerative Electrochemical Microfluidic Biosensors for Continual Monitoring of Cell Secretomes.

Authors:  Su Ryon Shin; Tugba Kilic; Yu Shrike Zhang; Huseyin Avci; Ning Hu; Duckjin Kim; Cristina Branco; Julio Aleman; Solange Massa; Antonia Silvestri; Jian Kang; Anna Desalvo; Mohammed Abdullah Hussaini; Su-Kyoung Chae; Alessandro Polini; Nupura Bhise; Mohammad Asif Hussain; HeaYeon Lee; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  Adv Sci (Weinh)       Date:  2017-03-06       Impact factor: 16.806

5.  Determination of Albumin, Glucose, and Creatinine Employing a Single Sequential Injection Lab-at-Valve with Mono-Segmented Flow System Enabling In-Line Dilution, In-Line Single-Standard Calibration, and In-Line Standard Addition.

Authors:  Kanokwan Kiwfo; Wasin Wongwilai; Tadao Sakai; Norio Teshima; Kate Grudpan
Journal:  Molecules       Date:  2020-04-04       Impact factor: 4.411

6.  Glucose Biosensor Based on Disposable Activated Carbon Electrodes Modified with Platinum Nanoparticles Electrodeposited on Poly(Azure A).

Authors:  Francisco Jiménez-Fiérrez; María Isabel González-Sánchez; Rebeca Jiménez-Pérez; Jesús Iniesta; Edelmira Valero
Journal:  Sensors (Basel)       Date:  2020-08-11       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.